NASDAQ:NH - NantHealth Stock Price, Price Target & More

$3.44 +0.09 (+2.69 %)
(As of 04/24/2018 04:00 PM ET)
Previous Close$3.35
Today's Range$3.35 - $3.48
52-Week Range$2.60 - $5.26
Volume58,221 shs
Average Volume116,727 shs
Market Capitalization$359.40 million
P/E Ratio-3.07
Dividend YieldN/A
Beta0.32

About NantHealth (NASDAQ:NH)

NantHealth logoNantHealth, Inc. is a healthcare cloud-based information technology (IT) company. The Company is engaged in converging science and technology through a single integrated clinical platform, to provide actionable health information at the point of care. The Company offers the Genomic Proteomic Spectrometry (GPS) Cancer test, a molecular test and decision support solution that measures the proteins present in the patient's tumor tissue, combined with whole genomic and transcriptomic sequencing of tumor and normal samples. The Company also offers Nant Operating System (NantOS) and NantOS applications to healthcare providers and payors, self-insured employers and biopharmaceutical companies. It offers CLINICS, an integrated solution that includes GPS Cancer, NantOS and the NantOS applications. The CLINICS solution includes System Infrastructure, Knowledge Platform, Provider Platform and Payor Platform.

Receive NH News and Ratings via Email

Sign-up to receive the latest news and ratings for NH and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Data processing & preparation
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:NH
CUSIPN/A
Phone310-883-1300

Debt

Debt-to-Equity Ratio1.01%
Current Ratio2.28%
Quick Ratio2.26%

Price-To-Earnings

Trailing P/E Ratio-3.07
Forward P/E Ratio-5.64
P/E GrowthN/A

Sales & Book Value

Annual Sales$86.68 million
Price / Sales4.31
Cash FlowN/A
Price / CashN/A
Book Value$1.78 per share
Price / Book1.93

Profitability

EPS (Most Recent Fiscal Year)($1.12)
Net Income$-175,210,000.00
Net Margins-188.81%
Return on Equity-54.16%
Return on Assets-27.35%

Miscellaneous

Employees494
Outstanding Shares108,580,000

How to Become a New Pot Stock Millionaire

NantHealth (NASDAQ:NH) Frequently Asked Questions

What is NantHealth's stock symbol?

NantHealth trades on the NASDAQ under the ticker symbol "NH."

How were NantHealth's earnings last quarter?

NantHealth Inc (NASDAQ:NH) released its quarterly earnings results on Wednesday, March, 14th. The company reported ($0.21) earnings per share for the quarter. The firm had revenue of $22.30 million for the quarter, compared to analysts' expectations of $23.50 million. NantHealth had a negative return on equity of 54.16% and a negative net margin of 188.81%. View NantHealth's Earnings History.

When is NantHealth's next earnings date?

NantHealth is scheduled to release their next quarterly earnings announcement on Tuesday, May, 8th 2018. View Earnings Estimates for NantHealth.

What price target have analysts set for NH?

3 brokerages have issued 12-month price targets for NantHealth's stock. Their predictions range from $4.50 to $5.00. On average, they anticipate NantHealth's share price to reach $4.8333 in the next twelve months. View Analyst Ratings for NantHealth.

Who are some of NantHealth's key competitors?

Who are NantHealth's key executives?

NantHealth's management team includes the folowing people:
  • Patrick Soon-Shiong M.D., Chairman of the Board, Chief Executive Officer, Founder (Age 64)
  • Paul A. Holt, Chief Financial Officer (Age 50)
  • Michael D. Blaszyk, Independent Director (Age 64)
  • Mark Burnett, Independent Director (Age 56)
  • Kirk K. Calhoun, Independent Director (Age 73)
  • Michael S. Sitrick, Independent Director (Age 69)

When did NantHealth IPO?

(NH) raised $91 million in an initial public offering on Thursday, June 2nd 2016. The company issued 6,500,000 shares at $12.50-$15.50 per share. Jefferies and Cowen and Company acted as the underwriters for the IPO and First Analysis Securities, Canaccord Genuity and FBR were co-managers.

Has NantHealth been receiving favorable news coverage?

Headlines about NH stock have been trending somewhat positive this week, according to Accern Sentiment Analysis. Accern rates the sentiment of news coverage by monitoring more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. NantHealth earned a coverage optimism score of 0.24 on Accern's scale. They also gave news coverage about the company an impact score of 46.05 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock's share price in the near future.

How do I buy shares of NantHealth?

Shares of NH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is NantHealth's stock price today?

One share of NH stock can currently be purchased for approximately $3.44.

How big of a company is NantHealth?

NantHealth has a market capitalization of $359.40 million and generates $86.68 million in revenue each year. The company earns $-175,210,000.00 in net income (profit) each year or ($1.12) on an earnings per share basis. NantHealth employs 494 workers across the globe.

How can I contact NantHealth?

NantHealth's mailing address is 9920 JEFFERSON BLVD, CULVER CITY CA, 90232. The company can be reached via phone at 310-883-1300 or via email at [email protected]


MarketBeat Community Rating for NantHealth (NH)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  149 (Vote Outperform)
Underperform Votes:  129 (Vote Underperform)
Total Votes:  278
MarketBeat's community ratings are surveys of what our community members think about NantHealth and other stocks. Vote "Outperform" if you believe NH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NH will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

NantHealth (NASDAQ:NH) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
3 Wall Street analysts have issued ratings and price targets for NantHealth in the last 12 months. Their average twelve-month price target is $4.8333, suggesting that the stock has a possible upside of 40.50%. The high price target for NH is $5.00 and the low price target for NH is $4.50. There are currently 3 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $4.8333$8.10$9.00$9.25
Price Target Upside: 40.50% upside167.33% upside152.81% upside105.56% upside

NantHealth (NASDAQ:NH) Consensus Price Target History

Price Target History for NantHealth (NASDAQ:NH)

NantHealth (NASDAQ:NH) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
3/21/2018Jefferies GroupSet Price TargetBuy$5.00HighView Rating Details
3/20/2018CowenReiterated RatingBuy$4.50LowView Rating Details
11/17/2017Canaccord GenuityLower Price TargetBuy -> Buy$6.00 -> $5.00N/AView Rating Details
4/3/2017Cantor FitzgeraldLower Price TargetOverweight$15.00 -> $13.00HighView Rating Details
4/1/2017FBR & CoSet Price TargetBuy$13.00HighView Rating Details
6/27/2016First AnalysisInitiated CoverageOverweight$18.00N/AView Rating Details
(Data available from 4/24/2016 forward)

Earnings

NantHealth (NASDAQ:NH) Earnings History and Estimates Chart

Earnings by Quarter for NantHealth (NASDAQ:NH)

NantHealth (NASDAQ:NH) Earnings Estimates

Current Year EPS Consensus Estimate: $-0.61 EPS
Next Year EPS Consensus Estimate: $-0.38 EPS

NantHealth (NASDAQ NH) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/8/2018($0.10)N/AView Earnings Details
3/14/2018Q4 2017($0.21)$23.50 million$22.30 millionViewN/AView Earnings Details
11/9/2017Q3 2017($0.14)($0.13)$29.42 million$21.76 millionViewN/AView Earnings Details
8/10/2017Q2 2017($0.26)($0.58)$31.28 million$26.23 millionViewN/AView Earnings Details
5/10/2017Q1 2017($0.20)($0.24)$29.06 million$22.51 millionViewN/AView Earnings Details
3/30/2017Q4 2016($0.19)($0.18)$30.02 million$24.10 millionViewN/AView Earnings Details
11/7/2016Q3 2016($0.27)($0.22)$26.05 million$25.36 millionViewN/AView Earnings Details
8/9/2016Q2 2016($0.65)($0.59)$23.45 million$31.49 millionViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

NantHealth (NASDAQ:NH) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

NantHealth (NASDAQ NH) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 58.00%
Institutional Ownership Percentage: 6.25%
Insider Trading History for NantHealth (NASDAQ:NH)
Insider Trading History for NantHealth (NASDAQ:NH)

NantHealth (NASDAQ NH) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/6/2018Ronald Allen LouksCOOSell7,005$3.04$21,295.2089,690View SEC Filing  
3/6/2018Ronald Allen LouksCOOSell7,095$3.56$25,258.2089,690View SEC Filing  
2/6/2018Ronald Allen LouksCOOSell6,475$3.02$19,554.5089,690View SEC Filing  
1/8/2018Ronald Allen LouksCOOSell6,175$3.52$21,736.0089,690View SEC Filing  
12/6/2017Ronald Allen LouksCOOSell5,245$3.03$15,892.3589,690View SEC Filing  
11/6/2017Ronald Allen LouksCOOSell6,705$3.39$22,729.9510,000View SEC Filing  
10/6/2017Ronald Allen LouksCOOSell26,820$4.28$114,789.60View SEC Filing  
6/7/2016Healthcare Solution AllscriptsMajor ShareholderBuy714,286$14.00$10,000,004.0015,000,000View SEC Filing  
6/7/2016Patrick Soon-ShiongCEOBuy357,143$14.00$5,000,002.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

NantHealth (NASDAQ NH) News Headlines

Source:
DateHeadline
NantHealth Inc (NH) COO Sells $21,295.20 in StockNantHealth Inc (NH) COO Sells $21,295.20 in Stock
www.americanbankingnews.com - April 10 at 10:16 PM
NantHealth (NH) Lowered to Sell at BidaskClubNantHealth (NH) Lowered to Sell at BidaskClub
www.americanbankingnews.com - April 6 at 7:00 PM
NantHealth (NH) Downgraded by Zacks Investment ResearchNantHealth (NH) Downgraded by Zacks Investment Research
www.americanbankingnews.com - April 5 at 5:46 PM
NantHealth Has Turned A CornerNantHealth Has Turned A Corner
seekingalpha.com - April 2 at 4:17 PM
NantHealth (NH) Downgraded by BidaskClubNantHealth (NH) Downgraded by BidaskClub
www.americanbankingnews.com - April 1 at 5:55 PM
Edited Transcript of NH earnings conference call or presentation 14-Mar-18 8:30pm GMTEdited Transcript of NH earnings conference call or presentation 14-Mar-18 8:30pm GMT
finance.yahoo.com - April 1 at 9:55 AM
NantHealth (NH) Raised to Sell at BidaskClubNantHealth (NH) Raised to Sell at BidaskClub
www.americanbankingnews.com - March 30 at 2:19 PM
NantHealth (NH) Lowered to "Hold" at Zacks Investment ResearchNantHealth (NH) Lowered to "Hold" at Zacks Investment Research
www.americanbankingnews.com - March 30 at 9:17 AM
NantHealth (NH) Lifted to Buy at Zacks Investment ResearchNantHealth (NH) Lifted to Buy at Zacks Investment Research
www.americanbankingnews.com - March 29 at 12:34 AM
NantHealth (NH) Upgraded to "Hold" by BidaskClubNantHealth (NH) Upgraded to "Hold" by BidaskClub
www.americanbankingnews.com - March 28 at 12:00 AM
NantHealth Inc (NH) Given Consensus Recommendation of "Buy" by AnalystsNantHealth Inc (NH) Given Consensus Recommendation of "Buy" by Analysts
www.americanbankingnews.com - March 27 at 1:38 AM
BidaskClub Upgrades NantHealth (NH) to HoldBidaskClub Upgrades NantHealth (NH) to Hold
www.americanbankingnews.com - March 24 at 12:28 PM
NantHealths (NH) CEO Dr. Patrick Soon-Shiong on Q4 2017 Results - Earnings Call Transcript - Seeking AlphaNantHealth's (NH) CEO Dr. Patrick Soon-Shiong on Q4 2017 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - March 22 at 4:10 PM
Jefferies Group Analysts Give NantHealth (NH) a $5.00 Price TargetJefferies Group Analysts Give NantHealth (NH) a $5.00 Price Target
www.americanbankingnews.com - March 21 at 7:48 PM
Cowen Reaffirms "Buy" Rating for NantHealth (NH)Cowen Reaffirms "Buy" Rating for NantHealth (NH)
www.americanbankingnews.com - March 20 at 1:17 PM
BRIEF-Nanthealth Inc Files For Mixed Shelf Of Up To $200 Million – SEC Filing‍BRIEF-Nanthealth Inc Files For Mixed Shelf Of Up To $200 Million – SEC Filing‍
www.reuters.com - March 17 at 9:57 AM
NantHealth Reports 2017 Fourth-Quarter and Full-Year Financial ResultsNantHealth Reports 2017 Fourth-Quarter and Full-Year Financial Results
finance.yahoo.com - March 14 at 5:24 PM
NantHealth Q4 Earnings PreviewNantHealth Q4 Earnings Preview
finance.yahoo.com - March 14 at 5:24 PM
Rockville biotech founded by L.A. billionaire to lay off 52Rockville biotech founded by L.A. billionaire to lay off 52
finance.yahoo.com - March 13 at 6:05 PM
NantHealth (NH) Set to Announce Earnings on WednesdayNantHealth (NH) Set to Announce Earnings on Wednesday
www.americanbankingnews.com - March 10 at 8:04 PM
NantHealth to Report 2017 Fourth-Quarter and Full-Year Financial Results and Host Conference Call on Wednesday ... - Business Wire (press release)NantHealth to Report 2017 Fourth-Quarter and Full-Year Financial Results and Host Conference Call on Wednesday ... - Business Wire (press release)
www.businesswire.com - March 9 at 10:35 AM
NantHealth to Report 2017 Fourth-Quarter and Full-Year Financial Results and Host Conference Call on Wednesday, March 14NantHealth to Report 2017 Fourth-Quarter and Full-Year Financial Results and Host Conference Call on Wednesday, March 14
finance.yahoo.com - March 9 at 10:35 AM
Ronald Allen Louks Sells 7,095 Shares of NantHealth Inc (NH) StockRonald Allen Louks Sells 7,095 Shares of NantHealth Inc (NH) Stock
www.americanbankingnews.com - March 8 at 9:50 PM
NantHealth to Present on the Future of Device Connectivity across the Continuum of Care at HIMSS18NantHealth to Present on the Future of Device Connectivity across the Continuum of Care at HIMSS18
finance.yahoo.com - March 5 at 4:47 PM
NantHealth Inc (NH) Given Consensus Recommendation of "Buy" by BrokeragesNantHealth Inc (NH) Given Consensus Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - March 2 at 1:32 AM
Reviewing NantHealth (NH) & Omnicell (OMCL)Reviewing NantHealth (NH) & Omnicell (OMCL)
www.americanbankingnews.com - February 27 at 3:06 AM
[$$] Former Officials Raise Questions About New LA Times Owner’s Business[$$] Former Officials Raise Questions About New LA Times Owner’s Business
finance.yahoo.com - February 12 at 8:56 AM
[$$] Former Officials Raise Questions About New LA Times Owners Business[$$] Former Officials Raise Questions About New LA Times Owner's Business
finance.yahoo.com - February 10 at 8:54 AM
Baltimore Sun parent Tronc to sell Los Angeles Times to L.A. billionaireBaltimore Sun parent Tronc to sell Los Angeles Times to L.A. billionaire
www.bizjournals.com - February 8 at 9:05 AM
Insider Selling: NantHealth Inc (NH) COO Sells 6,475 Shares of StockInsider Selling: NantHealth Inc (NH) COO Sells 6,475 Shares of Stock
www.americanbankingnews.com - February 8 at 4:20 AM
Tronc to sell Los Angeles Times: sourceTronc to sell Los Angeles Times: source
www.reuters.com - February 7 at 9:02 AM
Tronc to sell Los Angeles Times to L.A.’s richest personTronc to sell Los Angeles Times to L.A.’s richest person
www.bizjournals.com - February 7 at 9:02 AM
Tronc to sell the Los Angeles Times to billionaire biotech investor Patrick Soon-ShiongTronc to sell the Los Angeles Times to billionaire biotech investor Patrick Soon-Shiong
finance.yahoo.com - February 7 at 9:02 AM
Omnicell (OMCL) & NantHealth (NH) Financial AnalysisOmnicell (OMCL) & NantHealth (NH) Financial Analysis
www.americanbankingnews.com - February 6 at 5:10 AM
NantHealth Inc (NH) Given Average Recommendation of "Buy" by BrokeragesNantHealth Inc (NH) Given Average Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - February 5 at 1:28 AM
Head to Head Review: Press Ganey (PGND) vs. NantHealth (NH)Head to Head Review: Press Ganey (PGND) vs. NantHealth (NH)
www.americanbankingnews.com - February 3 at 11:04 AM
NantHealth: A Promising Individualized Medicine Company - Seeking AlphaNantHealth: A Promising Individualized Medicine Company - Seeking Alpha
seekingalpha.com - January 23 at 8:32 AM
NantHealth Inc (NH) Receives Consensus Rating of "Buy" from AnalystsNantHealth Inc (NH) Receives Consensus Rating of "Buy" from Analysts
www.americanbankingnews.com - January 11 at 1:10 AM
Ronald Allen Louks Sells 6,175 Shares of NantHealth Inc (NH) StockRonald Allen Louks Sells 6,175 Shares of NantHealth Inc (NH) Stock
www.americanbankingnews.com - January 9 at 7:56 PM
Contrasting Veeva Systems (VEEV) and NantHealth (NH)Contrasting Veeva Systems (VEEV) and NantHealth (NH)
www.americanbankingnews.com - January 9 at 7:32 AM
Greenway Health (GWAY) versus NantHealth (NH) Critical ComparisonGreenway Health (GWAY) versus NantHealth (NH) Critical Comparison
www.americanbankingnews.com - December 28 at 7:34 PM
Analyzing Veeva Systems (VEEV) and NantHealth (NH)Analyzing Veeva Systems (VEEV) and NantHealth (NH)
www.americanbankingnews.com - December 28 at 1:13 PM
NantHealth (NH) Stock Rating Lowered by Zacks Investment ResearchNantHealth (NH) Stock Rating Lowered by Zacks Investment Research
www.americanbankingnews.com - December 23 at 11:24 PM
NantHealth (NH) Upgraded to "Buy" by Zacks Investment ResearchNantHealth (NH) Upgraded to "Buy" by Zacks Investment Research
www.americanbankingnews.com - December 23 at 6:22 PM
Calculating The Intrinsic Value Of NantHealth Inc (NASDAQ:NH)Calculating The Intrinsic Value Of NantHealth Inc (NASDAQ:NH)
finance.yahoo.com - December 19 at 8:35 AM
NantHealth (NH) & The Competition Head-To-Head AnalysisNantHealth (NH) & The Competition Head-To-Head Analysis
www.americanbankingnews.com - December 18 at 11:10 PM
Critical Comparison: NantHealth (NH) versus The CompetitionCritical Comparison: NantHealth (NH) versus The Competition
www.americanbankingnews.com - December 18 at 1:46 PM
Reviewing NantHealth (NH) and The CompetitionReviewing NantHealth (NH) and The Competition
www.americanbankingnews.com - December 17 at 11:36 PM
NantHealth (NH) versus Fluidigm (FLDM) Critical ComparisonNantHealth (NH) versus Fluidigm (FLDM) Critical Comparison
www.americanbankingnews.com - December 15 at 11:16 PM
NantHealth (NH) & Its Competitors Head to Head ReviewNantHealth (NH) & Its Competitors Head to Head Review
www.americanbankingnews.com - December 15 at 7:10 PM

SEC Filings

NantHealth (NASDAQ:NH) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

NantHealth (NASDAQ:NH) Income Statement, Balance Sheet and Cash Flow Statement

Chart

NantHealth (NASDAQ NH) Stock Chart for Tuesday, April, 24, 2018

Loading chart…

This page was last updated on 4/24/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.